The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
/in Dendritic Cells, Glioblastoma, International PublicationsChemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity
/in Dendritic Cells, International PublicationsHarnessing the immune system for the treatment of non-small-cell lung cancer
/in International Publications, NSCLCCurrent status of immunotherapy for the treatment of biliary tract cancer
/in Dendritic Cells, Gallbladder Cancer, International PublicationsVaccine strategies for glioblastoma: progress and future directions
/in Dendritic Cells, Glioblastoma, International PublicationsComparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients
/in Dendritic Cells, Glioblastoma, International PublicationsBispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusProstate-specific antigen-retargeted recombinant newcastle disease virus for prostate cancer virotherapy
/in International Publications, Newcastle Disease Virus, Prostate CancerOncolytic virus therapy for cancer: the first wave of translational clinical trials
/in International Publications, Newcastle Disease Virus
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer